Researchers demonstrated that exosomes extracted from bone marrow MSCs (BMSC-exo) significantly promoted HFOB1.19 differentiation to osteoblasts, and found that BMSC-exo were enriched with miR-196a and delivered miR-196a to HFOB1.19 cells to inhibit its target Dkk1, which was a negative regulator of Wnt/β-catenin pathway.
[Bioengineered]
7992332
{7992332:BBBBBBBB}
apa
50
1
168461
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
